TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS
Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; pol |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LYSSIKATOS, JOSEPH P MUNSON, MARK C RAST, BRYSON DELISLE, ROBERT KIRK GROSS, STEFAN D DAVIS, T. GREGG TOPALOV, GEORGE T HICKEN, ERIK JAMES WRIGHT, A. DALE CELESTE, LAURA L ROBINSON, JOHN E ZHAO, QIAN KALLAN, NICHOLAS C PHENEGER, JED GRESCHUK, JULIE MARIE ALLEN, SHELLEY MARMSATER, FREDRIK P JACKSON, LEILA J SCHLACHTER, STEPHEN T |
| description | Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2334677TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2334677TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2334677TT33</originalsourceid><addsrcrecordid>eNrjZDAOCfJ0jPL38Q-IDPJ08fRzVXD29w3wD_VzCVZwDFYI8PRV8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT5GxsYmZubmISHGxsSoAQDd4ygE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><source>esp@cenet</source><creator>LYSSIKATOS, JOSEPH P ; MUNSON, MARK C ; RAST, BRYSON ; DELISLE, ROBERT KIRK ; GROSS, STEFAN D ; DAVIS, T. GREGG ; TOPALOV, GEORGE T ; HICKEN, ERIK JAMES ; WRIGHT, A. DALE ; CELESTE, LAURA L ; ROBINSON, JOHN E ; ZHAO, QIAN ; KALLAN, NICHOLAS C ; PHENEGER, JED ; GRESCHUK, JULIE MARIE ; ALLEN, SHELLEY ; MARMSATER, FREDRIK P ; JACKSON, LEILA J ; SCHLACHTER, STEPHEN T</creator><creatorcontrib>LYSSIKATOS, JOSEPH P ; MUNSON, MARK C ; RAST, BRYSON ; DELISLE, ROBERT KIRK ; GROSS, STEFAN D ; DAVIS, T. GREGG ; TOPALOV, GEORGE T ; HICKEN, ERIK JAMES ; WRIGHT, A. DALE ; CELESTE, LAURA L ; ROBINSON, JOHN E ; ZHAO, QIAN ; KALLAN, NICHOLAS C ; PHENEGER, JED ; GRESCHUK, JULIE MARIE ; ALLEN, SHELLEY ; MARMSATER, FREDRIK P ; JACKSON, LEILA J ; SCHLACHTER, STEPHEN T</creatorcontrib><description>Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.</description><language>eng ; pol</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140331&DB=EPODOC&CC=PL&NR=2334677T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140331&DB=EPODOC&CC=PL&NR=2334677T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LYSSIKATOS, JOSEPH P</creatorcontrib><creatorcontrib>MUNSON, MARK C</creatorcontrib><creatorcontrib>RAST, BRYSON</creatorcontrib><creatorcontrib>DELISLE, ROBERT KIRK</creatorcontrib><creatorcontrib>GROSS, STEFAN D</creatorcontrib><creatorcontrib>DAVIS, T. GREGG</creatorcontrib><creatorcontrib>TOPALOV, GEORGE T</creatorcontrib><creatorcontrib>HICKEN, ERIK JAMES</creatorcontrib><creatorcontrib>WRIGHT, A. DALE</creatorcontrib><creatorcontrib>CELESTE, LAURA L</creatorcontrib><creatorcontrib>ROBINSON, JOHN E</creatorcontrib><creatorcontrib>ZHAO, QIAN</creatorcontrib><creatorcontrib>KALLAN, NICHOLAS C</creatorcontrib><creatorcontrib>PHENEGER, JED</creatorcontrib><creatorcontrib>GRESCHUK, JULIE MARIE</creatorcontrib><creatorcontrib>ALLEN, SHELLEY</creatorcontrib><creatorcontrib>MARMSATER, FREDRIK P</creatorcontrib><creatorcontrib>JACKSON, LEILA J</creatorcontrib><creatorcontrib>SCHLACHTER, STEPHEN T</creatorcontrib><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><description>Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAOCfJ0jPL38Q-IDPJ08fRzVXD29w3wD_VzCVZwDFYI8PRV8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT5GxsYmZubmISHGxsSoAQDd4ygE</recordid><startdate>20140331</startdate><enddate>20140331</enddate><creator>LYSSIKATOS, JOSEPH P</creator><creator>MUNSON, MARK C</creator><creator>RAST, BRYSON</creator><creator>DELISLE, ROBERT KIRK</creator><creator>GROSS, STEFAN D</creator><creator>DAVIS, T. GREGG</creator><creator>TOPALOV, GEORGE T</creator><creator>HICKEN, ERIK JAMES</creator><creator>WRIGHT, A. DALE</creator><creator>CELESTE, LAURA L</creator><creator>ROBINSON, JOHN E</creator><creator>ZHAO, QIAN</creator><creator>KALLAN, NICHOLAS C</creator><creator>PHENEGER, JED</creator><creator>GRESCHUK, JULIE MARIE</creator><creator>ALLEN, SHELLEY</creator><creator>MARMSATER, FREDRIK P</creator><creator>JACKSON, LEILA J</creator><creator>SCHLACHTER, STEPHEN T</creator><scope>EVB</scope></search><sort><creationdate>20140331</creationdate><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><author>LYSSIKATOS, JOSEPH P ; MUNSON, MARK C ; RAST, BRYSON ; DELISLE, ROBERT KIRK ; GROSS, STEFAN D ; DAVIS, T. GREGG ; TOPALOV, GEORGE T ; HICKEN, ERIK JAMES ; WRIGHT, A. DALE ; CELESTE, LAURA L ; ROBINSON, JOHN E ; ZHAO, QIAN ; KALLAN, NICHOLAS C ; PHENEGER, JED ; GRESCHUK, JULIE MARIE ; ALLEN, SHELLEY ; MARMSATER, FREDRIK P ; JACKSON, LEILA J ; SCHLACHTER, STEPHEN T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2334677TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LYSSIKATOS, JOSEPH P</creatorcontrib><creatorcontrib>MUNSON, MARK C</creatorcontrib><creatorcontrib>RAST, BRYSON</creatorcontrib><creatorcontrib>DELISLE, ROBERT KIRK</creatorcontrib><creatorcontrib>GROSS, STEFAN D</creatorcontrib><creatorcontrib>DAVIS, T. GREGG</creatorcontrib><creatorcontrib>TOPALOV, GEORGE T</creatorcontrib><creatorcontrib>HICKEN, ERIK JAMES</creatorcontrib><creatorcontrib>WRIGHT, A. DALE</creatorcontrib><creatorcontrib>CELESTE, LAURA L</creatorcontrib><creatorcontrib>ROBINSON, JOHN E</creatorcontrib><creatorcontrib>ZHAO, QIAN</creatorcontrib><creatorcontrib>KALLAN, NICHOLAS C</creatorcontrib><creatorcontrib>PHENEGER, JED</creatorcontrib><creatorcontrib>GRESCHUK, JULIE MARIE</creatorcontrib><creatorcontrib>ALLEN, SHELLEY</creatorcontrib><creatorcontrib>MARMSATER, FREDRIK P</creatorcontrib><creatorcontrib>JACKSON, LEILA J</creatorcontrib><creatorcontrib>SCHLACHTER, STEPHEN T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LYSSIKATOS, JOSEPH P</au><au>MUNSON, MARK C</au><au>RAST, BRYSON</au><au>DELISLE, ROBERT KIRK</au><au>GROSS, STEFAN D</au><au>DAVIS, T. GREGG</au><au>TOPALOV, GEORGE T</au><au>HICKEN, ERIK JAMES</au><au>WRIGHT, A. DALE</au><au>CELESTE, LAURA L</au><au>ROBINSON, JOHN E</au><au>ZHAO, QIAN</au><au>KALLAN, NICHOLAS C</au><au>PHENEGER, JED</au><au>GRESCHUK, JULIE MARIE</au><au>ALLEN, SHELLEY</au><au>MARMSATER, FREDRIK P</au><au>JACKSON, LEILA J</au><au>SCHLACHTER, STEPHEN T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS</title><date>2014-03-31</date><risdate>2014</risdate><abstract>Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; pol |
| recordid | cdi_epo_espacenet_PL2334677TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T15%3A53%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LYSSIKATOS,%20JOSEPH%20P&rft.date=2014-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2334677TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |